Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome. (Q51535959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Christoph Ebenbichler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Anton Sandhofer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Markus Laimer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Bernhard Paulweber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Josef R Patsch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

760-768

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12805397%20AND%20SRC:MED&resulttype=core&format=json

The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Overfeeding rapidly induces leptin and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Leptin resistance is associated with hypothalamic leptin receptor mRNA and protein downregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Mouse placental cells secrete soluble leptin receptor (sOB-R): cAMP inhibits sOB-R production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

The serum growth hormone binding protein: pregnant with possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Soluble Leptin Receptor Represents the Main Leptin Binding Activity in Human Blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Cardiovascular morbidity and mortality associated with the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

The concept of selective leptin resistance: evidence from agouti yellow obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106

Circulating growth hormone binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.106